Market Overview

Esperion Therapeutics Spokesperson Says Co Pleased With PT Raise by Credit Suisse, Says Recognizes Value We Think We Have in ETC-1002

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for ESPR

DateFirmActionFromTo
Aug 2017Deutsche BankMaintainsBuy
Aug 2017JefferiesUpgradesHoldBuy
Jul 2017JefferiesInitiates Coverage OnHold

View More Analyst Ratings for ESPR
View the Latest Analyst Ratings

Posted-In: Credit SuisseAnalyst Color News Exclusives Analyst Ratings Movers

 

Related Articles (ESPR)

Partner Center